IP vs SPRB
International Paper (IP) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the IP and SPRB stock pages for the full models.
Not investment advice.